mRNA “Vaccine” GENOMIC INTEGRATION

/ 2025 / … First Direct Molecular Evidence of mRNA “Vaccine” GENOMIC INTEGRATION
Breaking the Silence: Synthetic mRNA, Genomic Instability, and the Path Forward
Decision Junction, 
Peter A. McCullough, MD, MPH,
and Nicolas Hulscher, MPH

In recent weeks, evidence has been mounting that the era of synthetic mRNA platforms carries consequences far more severe than policymakers, pharmaceutical corporations, and regulatory bodies have publicly acknowledged. A recently posted preprint study has confirmed what independent laboratories and clinicians have been warning: synthetic mRNA technologies are not simply transient messengers—they can drive persistent genetic instability, host–vector integration, and long-term molecular dysregulation.

The findings, now under peer review, echo concerns we have raised for years. This is not a matter of short-lived side effects or isolated complications; it is evidence of a structural failure of biological integrity triggered by a synthetic product once proclaimed to be “safe and effective.”
What the Preprint Confirms

The Preprints.org paper (202507.2155) corroborates these insights. The authors demonstrate that contamination from plasmid DNA templates—used in the production of mRNA vaccines—has introduced an additional pathway for genomic corruption. While many were reassured that mRNA could not alter DNA, this new evidence makes clear:

  • Plasmid DNA remnants can integrate into host genomes.
  • The observed somatic mutations are consistent with altered DNA stability.
  • RNA transcription chaos further compounds molecular instability, disrupting cellular programming and immune regulation.

This aligns with our real-world molecular surveillance observations. The problem is not theoretical—it is measurable in patients today.

Synthetic mRNA Vaccines and Transcriptomic Dysregulation: Evidence from New-Onset Adverse Events and Cancers Post-Vaccination[v1] | Preprints.org

Spike X Detect: Precision Beyond Diagnostics

At Neo7Bioscience, we designed Spike X Detect as a molecular surveillance platform to identify these aberrations in real-time. By combining next-generation sequencing, proteomics, and HLA-phenotyping, we identify not only the fingerprints of spike-related genomic corruption but also the personalized therapeutic targets needed to restore stability.

This dual role—detect and remediate—is critical. Unlike traditional diagnostics, which merely describe the problem, our platform is designed to counteract the aberrations through individualized peptide therapeutics.